Immunohistochemical detection of the lipid peroxidation product 4-hydroxynonenal after experimental brain injury in the rat

Neuroscience Letters

Volumn 272, Issue 1, 1999, Pages 57-61

  Polidori, M Cristina ^a,b   Mecocci, Patrizia ^a   Browne, Susan E ^b   Senin, Umberto ^a   Beal, M Flint ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Neurochemistry Laboratory   (United States)

Author keywords

Brain injury; Fluid percussion; Free radicals; Hydroxynonenal; Lipid peroxidation

Indexed keywords

4 HYDROXYNONENAL; FREE RADICAL; HYDROXYL RADICAL; 4-HYDROXY-2-NONENAL; ALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; ANIMAL; INJURY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALDEHYDES; ANIMALS; CEREBRAL CORTEX; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033520158     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00455-3     Document Type: Article

References (21)

1. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
2. Brouillet E., Hantraye P., Ferrante R.J., Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. USA. 92:1995;7105-7109.
3. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M.K., Bird E.D., Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41:1997;646-653.
4. Butterworth J., Yates C.M., Reynolds G.P. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase, and α-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases. J. Neurol. Sci. 67:1985;161-171.
5. Dizdaroglu M. Chemical determination of free radical-induced damage to DNA. Free Radic. Biol. Med. 10:1991;225-242.
6. Dragunow M., Faull R.L.M., Lawlor P., Beilharz E.J., Singleton K., Walker E.B., Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport. 6:1995;1053-1057.
7. Ferrante R.J., Kowall N.W., Hersch S.M., Brown R.H., Beal M.F. Immunohistochemical localization of markers for oxidative injury in Huntington's disease. Soc. Neurosci. Abstract. 22:1996;227.
8. Fraga C.G., Shigenaga M.K., Park J.W., Degan P., Ames B.N. Oxidative damage to DNA during ageing: 8-hydroxy-2-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA. 87:1990;4533-4537.
9. Irazu C.E., Rajagopalan P.R., Orak J.K., Fitts C.T., Singh I. Mitochondrial membrane fluidity changes in renal ischemia. J. Exp. Pathol. 5:1990;1-6.
10. Jenkins B.G., Koroshetz W.J., Beal M.F., Rosen B.R. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology. 43:1993;2685-2689.
11. Koroshetz, W.J., Jenkins, B.G., Rosen, B.R., Evidence for a metabolic disorder in Huntington's disease. Neurology, 44 (Suppl. 2) (1994) A338.
12. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
13. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.W., Beal M.F. Oxidative damage to DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34:1993;609-616.
14. Portera-Cailliau C., Hedreen J.C., Price D.L., Koliatos V.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
15. Sanchez-Ramos J.R., Overvik E., Ames B.N. A marker of oxyradical-mediated DNA damage (8-hydroxy-2-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration. 3:1994;197-204.
16. Schulz J.B., Matthews R.T., Muqit M.M.K., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
17. Shigenaga M.K., Ames B.N. Assays for 8-hydroxy-2-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic. Biol. Med. 10:1991;211-216.
18. Thomas L.B., Gates D.J., Richfield E.K., O'Brien T.F., Schweitzer J.B., Steindler D.A. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133:1995;265-272.
19. Troncoso J.C., Sukhov R.R., Kawas C.H., Koliatos V.E. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J. Neuropathol. Exp. Neurol. 55:1996;1134-1142.
20. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
21. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science. 256:1992;628-632.